Statements (54)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:disease
|
gptkbp:associated_with |
gptkb:Dengue_hemorrhagic_fever
gptkb:Dengue_fever |
gptkbp:caused_by |
gptkb:virus
|
gptkbp:clinical_use |
requires early intervention
requires monitoring requires fluid resuscitation requires supportive care |
gptkbp:community_health |
in urban areas
in endemic regions |
gptkbp:complication |
shock
organ failure hemorrhagic manifestations |
gptkbp:death |
higher in severe cases
1% to 5% with treatment up to 20% without treatment |
gptkbp:diagnosis |
clinical evaluation
laboratory tests |
gptkbp:diseases |
linked to climate change
linked to population movement linked to urbanization |
gptkbp:epidemiology |
tropical and subtropical regions
seasonal outbreaks |
gptkbp:first_described_by |
in the 1960s
|
gptkbp:geographic_distribution |
gptkb:Caribbean
gptkb:Latin_America gptkb:Southeast_Asia gptkb:Pacific_Islands |
gptkbp:healthcare_challenge |
in tropical climates
in high-density populations in low-resource settings |
https://www.w3.org/2000/01/rdf-schema#label |
Dengue shock syndrome
|
gptkbp:prevention |
vaccination
mosquito control |
gptkbp:research_focus |
treatment protocols
vaccine development vector control strategies |
gptkbp:risk_factor |
previous dengue infection
age under 12 |
gptkbp:symptoms |
fatigue
restlessness bleeding gums severe abdominal pain persistent vomiting rapid breathing |
gptkbp:transmission |
gptkb:Aedes_mosquitoes
|
gptkbp:treatment |
intravenous fluids
blood transfusion |
gptkbp:virus_serotype |
gptkb:DENV-1
gptkb:DENV-2 gptkb:DENV-3 gptkb:DENV-4 |
gptkbp:bfsParent |
gptkb:Dengue_fever
|
gptkbp:bfsLayer |
6
|